Legal & General Group PLC Sight Sciences, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 3,885 shares of SGHT stock, worth $13,714. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,885

Previous 3,885 -0.0%

Holding current value

$13,714

Previous $24,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.13 - $7.15 $6,458 - $9,001	1,259 Added 47.94%	3,885 $25,000
Q1 2024 May 14, 2024	SELL	$4.02 - $5.89 $12,574 - $18,423	-3,128 Reduced 54.36%	2,626 $13,000
Q4 2023 Feb 15, 2024	SELL	$1.29 - $5.86 $12,939 - $58,781	-10,031 Reduced 63.55%	5,754 $29,000
Q3 2023 Nov 14, 2023	SELL	$2.88 - $8.8 $26,824 - $81,963	-9,314 Reduced 37.11%	15,785 $53,000
Q2 2023 Aug 14, 2023	BUY	$7.46 - $10.67 $101,881 - $145,720	13,657 Added 119.36%	25,099 $207,000
Q1 2023 May 15, 2023	BUY	$8.44 - $13.35 $78,610 - $124,341	9,314 Added 437.69%	11,442 $100,000
Q4 2022 Feb 14, 2023	BUY	$5.58 - $13.94 $1,562 - $3,903	280 Added 15.15%	2,128 $25,000
Q2 2022 Aug 22, 2022	SELL	$6.61 - $11.99 $20,160 - $36,569	-3,050 Reduced 62.27%	1,848 $17,000
Q1 2022 May 16, 2022	BUY	$11.56 - $17.9 $13,201 - $20,441	1,142 Added 30.4%	4,898 $57,000
Q4 2021 Feb 14, 2022	BUY	$17.36 - $27.36 $45,951 - $72,421	2,647 Added 238.68%	3,756 $66,000
Q3 2021 Nov 15, 2021	BUY	$22.34 - $39.1 $24,775 - $43,361	1,109 New	1,109 $25,000

Others Institutions Holding SGHT

# of Institutions

Shares Held

21.6M

Call Options Held

66.8K

Put Options Held

13K

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $169M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Sight Sciences, Inc. Transaction History